Literature DB >> 2242561

Improved phenotyping of apolipoprotein E: application to population frequency distribution.

J S Hill1, P H Pritchard.   

Abstract

A simple procedure for phenotyping apolipoprotein (apo) E directly from plasma has been developed for use in the lipid clinic laboratory. In this new method, 10 microL of serum or plasma is pretreated with neuraminidase (EC 3.2.1.18), which removes the sialic acid residues from apo E and eliminates additional bands, thereby ensuring correct phenotype assignment. After a rapid delipidation step, the samples are focused in vertical polyacrylamide mini-slab gels and immunoblotted with a polyclonal goat anti-apo E antibody, followed by a Protein G-peroxidase conjugate. The accuracy of this method was confirmed by comparison with the established procedure of phenotyping by isoelectric focusing of delipidated very-low-density lipoprotein. In addition, sera from 203 subjects from Vancouver, selected without conscious bias, were used to determine the local distribution of the apo E alleles. We estimate that the relative frequencies of apo E alleles epsilon 2, epsilon 3, and epsilon 4 in this population are 0.086, 0.761, and 0.153, respectively. The speed and convenience of using minigels make this procedure ideal for clinical laboratory applications and large population studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242561

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma.

Authors:  Y Huang; A von Eckardstein; S Wu; G Assmann
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

2.  Dyslipidaemia in a boy with recurrent abdominal pain, hypersalivation and decreased lipoprotein lipase activity.

Authors:  D Matern; H Seydewitz; H Niederhoff; H Wiebusch; M Brandis
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

3.  Electrophoretic screening for human apolipoprotein C-II variants: repeated identification of apolipoprotein C-II(K19T).

Authors:  H Wiebusch; J R Nofer; A von Eckardstein; H Funke; U Wahrburg; H Martin; E Köhler; G Assmann
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

4.  Detection of apolipoprotein E phenotype in unconcentrated cerebrospinal fluid.

Authors:  P D Mehta; B A Patrick; T Pirttila; P K Coyle; P S Aisen
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

5.  Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians.

Authors:  Christophe Garenc; Samuel Aubert; Jèrôme Laroche; Joël Girouard; Marie-Claude Vohl; Jean Bergeron; François Rousseau; Pierre Julien
Journal:  J Hum Genet       Date:  2004-11-12       Impact factor: 3.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.